... to treatment outcomes among women with high-risk breast cancer, according to study results presented at San Antonio Breast Cancer Symposium.
News
- Tumor biology predicts breast cancer treatment outcomes more than race - Healio
- Oncolytics Biotech jumps 9% on positive data for breast cancer candidate | Seeking Alpha
Oncolytics Biotech (ONCY) gains 9.2% premarket after announcing a positive interim safety update from phase 2 IRENE trial at the 2021 San Antonio ...
- Texas Biomed breaks ground on animal care complex | TPR
File photo: Scientists at Texas Biomedical Research Institute in San Antonio used marmosets to help prevent birth defects caused by the Zika virus ...
- Novartis' New Kisqali Data Shows Consistent Overall Survival Benefit Across Metastatic ... - Benzinga
... presentation at the 2021 San Antonio Breast Cancer Symposium (SABCS). ... Posted in: BiotechNewsHealth CareGeneralbreast cancerBriefsPhase 3 ...
- Adicet soars on early clinical data for cancer cell therapy - San Francisco Business Times
Allogeneic therapies are a holy grail for cancer-focused biotech companies, promising to speed critical treatments into a broader range of health ...